eosinophilia-myalgia syndrome
GPTKB entity
Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:disease
|
| gptkbp:alsoKnownAs |
gptkb:EMS
|
| gptkbp:category |
autoimmune disease
toxin-induced disease |
| gptkbp:cause |
contaminated L-tryptophan supplements
|
| gptkbp:complication |
disability
chronic pain |
| gptkbp:diagnosedBy |
blood test
clinical evaluation |
| gptkbp:firstReported |
1989
|
| https://www.w3.org/2000/01/rdf-schema#label |
eosinophilia-myalgia syndrome
|
| gptkbp:notableOutbreaks |
gptkb:United_States
|
| gptkbp:prevention |
avoidance of contaminated L-tryptophan
|
| gptkbp:relatedTo |
toxic oil syndrome
|
| gptkbp:symptom |
peripheral neuropathy
eosinophilia myalgia skin changes |
| gptkbp:treatment |
corticosteroids
immunosuppressive drugs |
| gptkbp:bfsParent |
gptkb:Tryptophan
|
| gptkbp:bfsLayer |
6
|